Episode
#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
1:03:36
Published: Mon Jul 15 2019
Description
This episode features a panel that I moderated in front of a standing-room-only crowd at the Milken Institute's Global Conference 2019. It includes a great overview of psychedelic science, investing opportunities, anecdotal personal benefits, legal challenges, and much more. I think it’s one of the more comprehensive panels ever done on the subject. Here are the participants:Matthew Johnson — Principal Investigator, Johns Hopkins Psychedelic Research UnitAyelet Waldman — Author, A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My LifeRobin Carhart-Harris — Head of Psychedelic Research, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College LondonChristian Angermayer — Founder, Apeiron Investment Group and ATAI Life SciencesPlease enjoy!***If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it really makes a difference in helping to convince hard-to-get guests. I also love reading the reviews!For show notes and past guests, please visit tim.blog/podcast.Sign up for Tim’s email newsletter (“5-Bullet Friday”) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim’s books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissFacebook: facebook.com/timferriss YouTube: youtube.com/timferrissPast guests on The Tim Ferriss Show include Jerry Seinfeld, Hugh Jackman, Dr. Jane Goodall, LeBron James, Kevin Hart, Doris Kearns Goodwin, Jamie Foxx, Matthew McConaughey, Esther Perel, Elizabeth Gilbert, Terry Crews, Sia, Yuval Noah Harari, Malcolm Gladwell, Madeleine Albright, Cheryl Strayed, Jim Collins, Mary Karr, Maria Popova, Sam Harris, Michael Phelps, Bob Iger, Edward Norton, Arnold Schwarzenegger, Neil Strauss, Ken Burns, Maria Sharapova, Marc Andreessen, Neil Gaiman, Neil de Grasse Tyson, Jocko Willink, Daniel Ek, Kelly Slater, Dr. Peter Attia, Seth Godin, Howard Marks, Dr. Brené Brown, Eric Schmidt, Michael Lewis, Joe Gebbia, Michael Pollan, Dr. Jordan Peterson, Vince Vaughn, Brian Koppelman, Ramit Sethi, Dax Shepard, Tony Robbins, Jim Dethmer, Dan Harris, Ray Dalio, Naval Ravikant, Vitalik Buterin, Elizabeth Lesser, Amanda Palmer, Katie Haun, Sir Richard Branson, Chuck Palahniuk, Arianna Huffington, Reid Hoffman, Bill Burr, Whitney Cummings, Rick Rubin, Dr. Vivek Murthy, Darren Aronofsky, and many more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Chapters
In this episode, a panel of experts discuss the current state of psychedelic science and potential benefits of psychedelic-assisted therapies.
00:00 - 04:17 (04:17)
Summary
In this episode, a panel of experts discuss the current state of psychedelic science and potential benefits of psychedelic-assisted therapies. The panel was recorded at the 2019 Milken Institute Global Conference.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
Recent studies indicate that psilocybin may be approved as a Schedule Four medicine due to its low abuse liability and potential benefits for treating anxiety and depression in just a single high-dose session.
04:17 - 10:31 (06:14)
Summary
Recent studies indicate that psilocybin may be approved as a Schedule Four medicine due to its low abuse liability and potential benefits for treating anxiety and depression in just a single high-dose session.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
Research in the field is showing the potential of psychedelics in treating psychiatric disorders with trials replicating results from previous research in the 1950s to 1970s.
10:31 - 16:31 (06:00)
Summary
Research in the field is showing the potential of psychedelics in treating psychiatric disorders with trials replicating results from previous research in the 1950s to 1970s. The effectiveness of antidepressants is also questioned, with their commercials not accurately depicting their effects.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
The mental health industry has been neglected over the last 30 years, however, with the rise in mental health issues, there is a growing need for focus in this area through tangible illnesses such as depression and other psychedelic treatments.
16:36 - 27:50 (11:14)
Summary
The mental health industry has been neglected over the last 30 years, however, with the rise in mental health issues, there is a growing need for focus in this area through tangible illnesses such as depression and other psychedelic treatments.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
The major risk of classic psychedelics is associated only with one or two percent of the population who have an active psychotic disorder.
27:50 - 38:03 (10:12)
Summary
The major risk of classic psychedelics is associated only with one or two percent of the population who have an active psychotic disorder. A rare condition called hallucinogen is also associated only with recreational use and typically with multiple drugs use including alcohol.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
Brain imaging allows us to lift the lid on the black box that's the brain and achieve a better understanding of addiction and other disorders.
38:04 - 45:48 (07:43)
Summary
Brain imaging allows us to lift the lid on the black box that's the brain and achieve a better understanding of addiction and other disorders. Medication-assisted treatments can help tackle the opioid crisis, which is resistant to treatment.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
The intersection of biotech and mental health is a growing field.
45:48 - 52:23 (06:34)
Summary
The intersection of biotech and mental health is a growing field. Biotech investors are interested in finding ways to not only treat those with mental health issues but also keep people healthy.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
The podcast discusses the Schedule One category and how marijuana ended up in it despite its potential medical use and low toxicity.
52:23 - 1:01:53 (09:30)
Summary
The podcast discusses the Schedule One category and how marijuana ended up in it despite its potential medical use and low toxicity. It also talks about the lack of a category for substances with mild to moderate abuse potential but no accepted medical use.
Episode#377: Psychedelics — Microdosing, Mind-Enhancing Methods, and More
PodcastThe Tim Ferriss Show
The Four Hour Work Week website offers a weekly email newsletter called Five Bullet Friday, where subscribers receive a short email every Friday containing interesting discoveries and musings from the week.
1:01:53 - 1:03:29 (01:35)
Summary
The Four Hour Work Week website offers a weekly email newsletter called Five Bullet Friday, where subscribers receive a short email every Friday containing interesting discoveries and musings from the week.